 |
|
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol. 2021;27(1):87-90. Published online 2020 Dec 3 DOI: https://doi.org/10.3350/cmh.2020.0302
|
|
Citations to this article as recorded by
 Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma
Alok Raghav, Goo Bo Jeong
Cells.2024; 13(7): 638. CrossRef The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99. CrossRef Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clinical and Molecular Hepatology.2023; 29(2): 433. CrossRef Occurrence of Liver Cancer in People without Traditional Risk Factors
Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
Korean Journal of Clinical Geriatrics.2023; 24(1): 41. CrossRef The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu
Advanced Gut & Microbiome Research.2023; 2023: 1. CrossRef Bursatella leachii Purple Ink Secretion Concentrate Exerts Cytotoxic Properties against Human Hepatocarcinoma Cell Line (HepG2): In Vitro and In Silico Studies
Zeyad I. Alehaideb, Anuradha Venkatraman, Mahadev Kokane, Syed Ali Mohamed, Saranya Rameshbabu, Rasha S. Suliman, Sahar S. Alghamdi, Hamad Al-Eidi, Bandar Alghanem, Maha-Hamadien Abdulla, Sabine Matou-Nasri
Molecules.2022; 27(3): 826. CrossRef The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
Frontiers in Oncology.2022;[Epub] CrossRef Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
BMC Cancer.2022;[Epub] CrossRef Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
Joo Hyun Oh, Je Hee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang
Nutrients.2021; 13(3): 1013. CrossRef Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Cancers.2021; 13(14): 3424. CrossRef Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
Translational Oncology.2021; 14(9): 101158. CrossRef Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef
|